Blood urea nitrogen-to-albumin ratio as a predictor of mortality in patients undergoing emergency surgery for obstructive colon cancer

血尿素氮与白蛋白比值作为接受急诊手术治疗梗阻性结肠癌患者死亡率的预测指标

阅读:2

Abstract

BACKGROUND: Mortality rates are high in patients undergoing emergency surgery for obstructed colon adenocarcinoma. The etiology of mortality is multifactorial, and parameters with high predictive value are still needed. The aim of this study was to investigate the relationship between the blood urea nitrogen-to-serum albumin ratio (BAR) and short-term mortality in patients with obstructed colon cancer undergoing emergency surgery. METHODS: This retrospective cohort study included patients with obstructed colon adenocarcinoma who underwent emergency surgery at two tertiary care centers between January 2015 and December 2024. Baseline characteristics, laboratory findings, operative details, and clinical data were collected. According to time-dependent receiver operating characteristics (ROC) analysis, the optimal cut-off value for pretreatment BAR was 0.68. Data from patients who died within the first 30 days and those who survived were compared. Univariate and multivariate Cox regression analyses were performed to evaluate the association between BAR and other factors with early mortality. RESULTS: A total of 173 patients underwent emergency surgery, and 17 (9.8%) experienced early mortality. In multivariate logistic regression analysis, age (≥75 years), lactate level, neutrophil count, and BAR ≥0.68 (odds ratio: 7.053; 95% confidence interval: 1.728-28.785; p=0.006) were identified as significant risk factors for early mortality in patients undergoing emergency surgery for obstructed colon cancer. CONCLUSION: Mortality in patients undergoing emergency surgery for obstructed colon cancer is high and multifactorial. BAR is a cost-effective, easily measurable, and useful predictor of early mortality.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。